Evaluation of Treatment Benefit in Journal of Clinical Oncology

 Blogger's Note: also speaks to the issues of rare cancers

Evaluation of Treatment Benefit in Journal of Clinical Oncology

REFERENCES

1. ↵
   1. Byar DP

   (1980) Why data bases should not replace randomized clinical trials. Biometrics 36:337–342.

   CrossRefMedline
2. ↵
   1. Levine MN,
   2. Julian JA

   (2008) Registries that show efficacy: Good, but not good enough. J Clin Oncol 26:5316–5319.

   FREE Full Text
3. ↵
   1. Patsopoulos NA

   (2011) A pragmatic view on pragmatic trials. Dialogues in Clinical Neuroscience 13:217–224.

   Medline
4. ↵
   1. Sox HC,
   2. Greenfield S

   (2009) Comparative effectiveness research: A report from the Institute of Medicine. Ann Intern Med 151:303–205.

   Search Google Scholar
5. ↵
   1. Verweij J,
   2. Disis ML,
   3. Cannistra SA

   (2010) Phase I studies of drug combinations. J Clin Oncol 30:4545–4546.

   Search Google Scholar
6. ↵
   1. Cannistra S

   (2009) Phase II trials in Journal of Clinical Oncology. J Clin Oncol 27:3073–3076.

   FREE Full Text